Archive

Radio Cherwell of the Oxfords Hospitals’ Broadcasting Association (OHBA).

Features an interview with Dr Adam Hardy on anti-cancer drug development and chronotherapy.

The Oxford Times, inbusiness supplement, 19 September 2008. Creating targeted medicine.

"Nigel Wild, head of consultancy Nigel Wild Associates, discovers how computers are being used to predict the effectiveness of cancer drugs". Features an interview of Dr Christophe Chassagnole, Physiomics Chief Operating Officer.

The National, 7 September 2008.

Prescriptions may soon work around the clock. Robert Matthews article in Abu Dhabi daily newspaper, featuring Physiomics' work on chronotherapy.

New Scientist, issue 2671, pages 6-7.

Circadian rhythms boost cancer therapies. Features Physiomics' work on chronotherapy.

Physiomics Technology in continued and expanded support of Lilly’s Oncology Programs

Physiomics plc (AIM: PYC), the Oxford, UK based systems biology company, is pleased to announce that it has signed a further agreement with Eli Lilly and Company ('Lilly') (NYSE: LLY), the global pharmaceutical company, to perform two new projects for in silico simulations in the field of oncology. Financial details of this agreement have not been disclosed. This follows the successful completion earlier this year of a specific project studying cancer cellular processes for drugs targeting the cell cycle (the natural process of controlling cell proliferation)

BBC Focus Magazine, issue 187, pages 55-59.

The new Holism. Features an interview with Dr David Orrell on systems biology and our work at Physiomics.

Art Center Global Dialogues on Disruptive Thinking

Barcelona, Spain. Dr David Orrell speaks about the disruptive effect of the systems approach to science.

Physiomics to present on Chronotherapy at the Annual Meeting of American Association of Cancer Research (“AACR”)

Physiomics plc, the Oxford, UK based systems biology company, is pleased to announce that it will be participating in the 2008 AACR Annual Meeting, taking place in San Diego, on 12-16 April 2008. Dr Eric Fernandez will present a development update on the Company’s chronotherapy research program, as part of the EU funded TEMPO (Temporal Genomics for Tailored Chronotherapeutics) project. The abstract will be published in the 2008 Proceeding of the AACR and will be presented in the poster session “Cellular and Molecular Biology 8”, scheduled for 1:00 pm on 13 April.

Bio-ITWorld Systems Biology eNewsletter

Progress for Physiomics.